WuXi Biologics Competitors and Similar CompaniesClear all
WuXi Biologics's competitors and similar companies include Evotec, Catalent, Lonza, Samsung Biologics and Fujifilm Diosynth Biotechnologies.
 WuXi Biologics WuXi Biologics (药明生物) is a company operating as an open-access technology platform for biologics drug development. |  Catalent Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products. |  Samsung Biologics Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization. |  Fujifilm Diosynth Biotechnologies Fujifilm Diosynth Biotechnologies U.S.A. is a contract development and manufacturing organization operating in the biopharmaceutical industry. | |||
Founding Date | Founding Date 2010 | Founding Date 1993 | Founding Date 2007 | Founding Date 1897 | Founding Date 2011 | Founding Date 2011 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | ||||||
Locations | Locations Wuxi, CN HQ George Town, KY Wuppertal, DE Hong Kong, HK Dundalk, IE Cranbury, US King Of Prussia, US | Locations Hamburg, DE HQ Lyon, FR Toulouse, FR Göttingen, DE Halle (Westfalen), DE Köln, DE Munich, DE see more | Locations Bridgewater, US HQ Buenos Aires, AR Bruxelles, BE Charleroi, BE Charleroi, BE Charleroi, BE Indaiatuba, BR see more | Locations Basel, CH HQ Baulkham Hills, AU Antwerpen, BE Bornem, BE Verviers, BE Rio De Janeiro, BR Dorval, CA see more | Locations Incheon, KR HQ Boston, US Ridgefield Park, US South San Francisco, US | Locations Morrisville, US HQ Hillerød, DK Stockton On Tees, GB College Station, US |
Employees | Employees 12,575 | Employees 4,766 | Employees 12,6955% increase | Employees 19,7712% increase | Employees 4,770 | Employees 5,3942% increase |
Financial | ||||||
Revenue (est.) | Revenue (est.) ¥21.8b (FY, 2025) | Revenue (est.) €788.4m (FY, 2025) | Revenue (est.) $4.4b (FY, 2024) | Revenue (est.) CHF6.5b (FY, 2025) | Revenue (est.) ₩4.6t (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥10b (FY, 2025) | Cost of goods €622.9m (FY, 2025) | Cost of goods $3.4b (FY, 2024) | Cost of goods CHF2.1b (FY, 2025) | Cost of goods ₩1.4t (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥12b (FY, 2025) | Gross profit €231.1m (FY, 2025) | Gross profit $953m (FY, 2024) | Gross profit CHF4.5b (FY, 2025) | Gross profit ₩3.1t (FY, 2025) | Gross profit N/A |
Net income | Net income ¥5.7b (FY, 2025) | Net income (€103.5m) (FY, 2025) | Net income ($1b) (FY, 2024) | Net income CHF909m (FY, 2025) | Net income ₩1.6t (FY, 2025) | Net income N/A |
Operating ⚠ | ||||||
Backlog | Backlog $18.5b (H1, 2022) | Backlog N/A | Backlog $2.5b (FY, 2023) | Backlog N/A | Backlog N/A | Backlog N/A |
Countries | Countries N/A | Countries N/A | Countries 80 (FY, 2023) | Countries 28 (FY, 2022) | Countries N/A | Countries N/A |
Customers | Customers N/A | Customers 781 (FY, 2023) | Customers 1.2 k (FY, 2023) | Customers N/A | Customers N/A | Customers N/A |
Products | Products N/A | Products 140 (FY, 2023) | Products 8 k (FY, 2023) | Products N/A | Products N/A | Products N/A |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 993.6m | Total funding raised $ 650m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 850m |
For sources of this data, please see the company profile
View Company Profiles
Evotec
HQ
Hamburg, DE
Employees
4,766
Evotec is a biotechnology company that provides drug discovery and development services.
View companyCatalent
HQ
Bridgewater, US
Catalent is a company that develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, vaccines, and consumer health products.
View company
Lonza
HQ
Basel, CH
Employees
19,771↑ 2% increase
Lonza Group is a company specializing in life sciences and biotechnology solutions
View companySamsung Biologics
HQ
Incheon, KR
Employees
4,770
Samsung Biologics (삼성바이오로직스) is a contract development and manufacturing organization.
View company